UNSPSC 51241103: Bimatoprost

This classification denotes a prostaglandin analogue and anti-glaucoma agent with the molecular formula C25H37NO4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier QXS94885MZ, chemically known as 5-heptenamide, 7-(3,5-dihydroxy-2-(3-hydrdoxy-5-phenyl-1-pentenyl)cyclopentyl)-n-ethyl-, (1r-(1alpha(z),2beta(1e,3s*),3alpha,5alpha))- but generally known as bimatoprost, which bears US NIH Compound Identifier 5311027.

UNSPSC 51241103 Bimatoprost is a Commodity code identifying a specific pharmaceutical product — a prostaglandin analog used primarily to treat elevated intraocular pressure in glaucoma and ocular hypertension. State and local governments procure bimatoprost through health department pharmaceutical purchasing, institutional pharmacy operations at public hospitals and clinics, and correctional health systems. The product is sourced as a branded or generic formulation, typically ophthalmic solution, and appears in competitive solicitations alongside other glaucoma medications or as part of broader institutional pharmacy supply contracts. Issuing bodies include state health departments, county and municipal public health agencies, public hospital systems, and departments of corrections.

The source provides no recent state and local contract opportunities tagged to this code. Activity data necessary to characterize geographic distribution, issuing-body concentration, or representative recent solicitations is not present.